Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre-Reference-Cited by-同舟云学术

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre

Published:2019-02-15 Issue:5 Volume:28 Page:680-689
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Star Kristina¹²^ORCID,Sandberg Lovisa¹,Bergvall Tomas¹,Choonara Imti³,Caduff‐Janosa Pia¹,Edwards I. Ralph¹

Affiliation:

1. Research SectionUppsala Monitoring Centre Uppsala Sweden

2. Department of Public Health and Caring SciencesUppsala University Uppsala Sweden

3. Division of Medical Sciences and Graduate Entry MedicineUniversity of Nottingham Derby UK

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4734

Reference49 articles.

1. Uppsala Monitoring Centre. Available from:https://www.who‐umc.org/. Accessed Apr 27 2018.

2. Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions

3. Council for International Organisations of Medical Sciences (CIOMS) Working Group VIII.Practical aspects of signal detection in pharmacovigilance CIOMS;2010.

4. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre

5. A Bayesian neural network method for adverse drug reaction signal generation

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving role of disproportionality analysis in pharmacovigilance;Expert Opinion on Drug Safety;2024-06-24

2. Evaluation of Adverse Drug Events in Patients on Anti-Retroviral Therapy Regimen at Omdurman Voluntary Counselling and Testing and Anti-Retroviral Therapy Center in Sudan – A Cross-Sectional Study;HIV/AIDS - Research and Palliative Care;2024-04

3. Safe Prescribing and Drug Use in Pregnancy and Breastfeeding;Principles and Practice of Pharmacovigilance and Drug Safety;2024

4. Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications;Pharmacy;2023-11-09

5. Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010–2020: A Cross-Sectional Study;Therapeutic Innovation & Regulatory Science;2023-06-23